Microphone, The Market Online logo and The 5 Minute Investor Podcast logo. (Source: Stockhouse)

Welcome to episode 55 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and Trevor Abes each deliver a 2.5-minute profile on stocks related to recent news stories with investment implications. This week, with oil surpassing US$110 per barrel, we’re profiling a pair of stocks with the potential to help you hedge your portfolio against energy market volatility.

Here are Jon’s show notes for episode 55:

  • A cash‑flow hedge for a $100 oil world.
  • Jon’s stock with strong potential to hedge against high oil prices is Cenovus Energy (TSX/NYSE:CVE), an integrated oil and gas company operating in Canada, the United States and Asia that produced nearly 700,000 barrels of oil and natural gas liquids in 2025.
  • At the time of writing, Cenovus stock last traded at C$36.65, adding 129 per cent year-over-year.

Here are Trevor’s show notes:

Here’s the most recent trio of episodes:

Thanks for listening!

The 5-Minute Investor Podcast is on SpotifyYouTubeiHeartRadio, Stockhouse or wherever finer podcasts are found.

Join the discussion: Find out what investors are saying about these hedges against rising oil prices on the Cenovus Energy Inc. and Thunder Gold Corp. Bullboards, and make sure to explore the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.

For full disclaimer information, please click here.


More From The Market Online

Trump administration touts junior copper miner

Junior miner Highland Copper (TSXV:HI) receives a nod in a new publication from the Trump administration about the US mining industry.

Soleno Therapeutics shares jump nearly 40% on $2.9 billion takeout deal

Soleno Therapeutics (NASDAQ:SLNO) shares rallied after Neurocrine Biosciences agreed to acquire the company for US$2.9 billion.

@ the Bell: Markets steady as ceasefire hopes offset Middle East tensions

Canada’s main stock index was little changed on Monday amid light trading, as investors returned from...

Vireo founds NY’s first minority-owned medical cannabis company at scale

Vireo Growth partners with Ace Venture of NY to establish New York's first minority-owned vertically integrated medical cannabis company.